Active Amphiregulin (AREG)
AR; CRDGF; SDGF; Colorectum Cell-Derived Growth Factor; Schwannoma-Derived Growth Factor
- Product No.APA006Hu01
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- Traits Freeze-dried powder
- Purity> 90%
- Isoelectric Point5.1
- ApplicationsCell culture; Activity Assays.
- DownloadInstruction Manual
- UOM 10µg50µg 200µg 1mg 5mg
- FOB
US$ 192
For more details, please contact local distributors! US$ 480 US$ 960 US$ 2880 US$ 7200
ACTIVITY TEST
Amphiregulin (AREG) is a well-characterized member of the epidermal growth factor (EGF) family and is one of the ligands of the EGF receptor (EGFR). AREG plays a key role in mammalian development and in the control of branching morphogenesis in various organs. Furthermore, AREG participates in a wide range of physiological and pathological processes activating the major intracellular signalling cascades governing cell survival, proliferation and motility. Besides, EGF has been identified as an interactor of AREG, thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human AREG and recombinant rat EGF. Briefly, AREG was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to EGF-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-AREG pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 µL stop solution to the wells and read at 450/630 nm immediately. The binding activity of recombinant human AREG and recombinant rat EGF was shown in Figure 1, the EC50 for this effect is 0.1 ug/mL.
USAGE
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
GIVEAWAYS
INCREMENT SERVICES
- BCA Protein Quantification Kit
- Molecular Mass Marker for Protein
- Monoclonal Antibody Customized Service
- Polyclonal Antibody Customized Service
- Protein Activity Test Experiment Service
- Electrophoretic Mobility Shift Assay (EMSA) Experiment Service
- Buffer
- Lentivirus Packaging Experiment Service
- Adenovirus Packaging Experiment Service
- Real Time PCR Experimental Service
- Spike RBD Protein (S-RBD)
- Protein G
- Protein A
Magazine | Citations |
Onkologie | Amphiregulin and Epiregulin Expression in Colorectal Carcinoma and the Correlation with Clinicopathological Characteristics Karger: 315380 |
Br J Cancer. | Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer. Pubmed:24800946 |
Cancer Sci | Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer PubMed: 25707609 |
J Cancer Res Clin Oncol | Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer PubMed: 26195282 |
Oncotarget. | Serum level of hepatocyte growth factor is a novel marker of predicting theoutcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancer Pubmed:26716644 |
Acta Pharmacologica Sinica | Anti-asthmatic activity of alkaloid compounds from Pericarpium Citri Reticulatae (Citrus reticulata 'Chachi') Pubmed: 19363516 |
International Journal of Biological Sciences | CD9 regulates keratinocyte migration by negatively modulating the sheddase activity of ADAM17 |
Neoplasia | Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine Pubmed: 33212364 |
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | Polarization of ADAM17‐driven EGFR signalling in electric field‐guided collective migration of epidermal sheets Pubmed: 33164313 |
Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
APA006Hu01 | Active Amphiregulin (AREG) | Cell culture; Activity Assays. |
RPA006Hu01 | Recombinant Amphiregulin (AREG) | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA006Hu01 | Polyclonal Antibody to Amphiregulin (AREG) | WB; IHC; ICC; IP. |
MAA006Hu23 | Monoclonal Antibody to Amphiregulin (AREG) | WB; IHC; ICC; IP. |
MAA006Hu25 | Monoclonal Antibody to Amphiregulin (AREG) | WB; IHC; ICC; IP. |
MAA006Hu22 | Monoclonal Antibody to Amphiregulin (AREG) | WB; IHC |
MAA006Hu24 | Monoclonal Antibody to Amphiregulin (AREG) | WB; IHC; ICC/IF |
MAA006Hu26 | Monoclonal Antibody to Amphiregulin (AREG) | WB; IHC |
MAA006Hu21 | Monoclonal Antibody to Amphiregulin (AREG) | WB; IHC; ICC; IP. |
MAA006Hu27 | Monoclonal Antibody to Amphiregulin (AREG) | WB; IHC; ICC; IP. |
MAA006Hu29 | Monoclonal Antibody to Amphiregulin (AREG) | WB; IHC; ICC; IP. |
LAA006Hu76 | Biotin-Linked Monoclonal Antibody to Amphiregulin (AREG) | WB; IHC; ICC. |
SEA006Hu | ELISA Kit for Amphiregulin (AREG) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCA006Hu | CLIA Kit for Amphiregulin (AREG) | Chemiluminescent immunoassay for Antigen Detection. |
LMA006Hu | Multiplex Assay Kit for Amphiregulin (AREG) ,etc. by FLIA (Flow Luminescence Immunoassay) | FLIA Kit for Antigen Detection. |
PSA006Hu01 | Antibody Pair for Amphiregulin (AREG) | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSA006Hu01 | ELISA Kit DIY Materials for Amphiregulin (AREG) | Main materials for "Do It (ELISA Kit) Yourself". |